Pages
How does diversity affect the way our colleagues and patients experience health and health services?
Freedom to speak up animations
We have developed a series of animations based on issues staff have raised a concern about in DCHS. We hope they help you make your decision about whether you should raise a concern.
https://dchs.nhs.uk/my_dchs/how-do-i/freedom-to-speak-up/freedom-speak-animations
Volunteer application form
Volunteer application form
https://dchs.nhs.uk/join-us/volunteer-with-us/volunteer-application-form
Accessibility Statement
Accessibility statement for www.dchs.nhs.uk
Bakewell’s new Newholme Health Centre – latest updates and project plans
https://dchs.nhs.uk/our-services/our-clinicshealth-centres/bakewell-integrated-health-hub
Files
APPENDIX 4 Application for Adoption Leave and Pay Form.docx
Organisational strategy - Bitesize slides - Healthy Communities.pptx
Organisational strategy - Bitesize slides - Healthy Communities.pptx
Requesting GP Prescribing SOP (S147)
To enable non-prescribing clinicians access to an internal group of DCHS prescribers to ensure patients receive clinically indicated medicines in a timely way without putting undue pressure on Community GPs within the system.
Derbyshire_Community_Health_Services_NHS_Foundation_Trust_licence.pdf
DCHS licence
Dressing Formulary and Wound Care Guidelines (G68)
The Derbyshire Wound Care and dressing formulary has been revised in collaboration with the East Midlands Wound Care Formulary Group. Work has been undertaken to provide a clinically effective, appropriate and cost effective choices of products to manage the vast majority of wounds. The formulary is available for all practitioners working for Derbyshire Community Health Services and Primary Care Services. It is expected that prescribers will preferentially use the products listed in the guide for routine use and be able to provide robust rationale where they have prescribed outside the formulary.
Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)
The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.
Ward-Decoration-Guidelines.docx
Christmas 2021 - IP&C guidance
DCHS Community Podiatry eligibility leaflet (2020).pdf
DCHS Community Podiatry eligibility leaflet (2020)
Community services visiting you at home _1.pdf
Appendix 9 - PCR Testing (Procedure and Transportation)
Appendix 9: PCR Testing (Procedure and Transportation) - Section 5.28 Covid-19 IP&C Policy